# OnCo record nct04554914 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04554914/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04554914", "NCT04554914" ;
  schema:name "A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases"@en ;
  schema:alternateName "EBVision"@en ;
  schema:description "A phase 2 trial of Tabelecleucel in brain and spinal cord tumours, sarcomas and uterine sarcoma, run by Pierre Fabre Medicament, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04554914/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04554914> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2021-07-14" ;
  onco:cancers <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/uterine-sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/virus-specific-t-cells/> ;
  onco:drugs <https://onco.cc/drugs/tabelecleucel/> ;
  onco:companies <https://onco.cc/companies/pierre-fabre/> .